✦ LIBER ✦

Impact of efalizumab on patient-reported outcomes in patients with moderate to severe plaque psoriasis: pooled results from three randomized phase III trials

✍ Scribed by Alan Menter; Tiffani Hamilton; Ivor Caro; Amy Chen-Rundle

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of efalizumab in a l

✍ Kenneth Gordon; David Pariser; Richard Langley; Ivor Caro 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 57 KB

CLinical experience acquired with the ef

✍ L. Dubertret; W. Sterry; J.D. Bos; S. Chimenti; S. Shumack; C.G. Larsen; N.H. Sh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB

Clinical Efficacy of Efalizumab in Patie

✍ David M. Pariser; Kenneth B. Gordon; Kim A. Papp; Craig L. Leonardi; Paul Kwon; 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 201 KB

Long-term continuous efalizumab therapy

✍ Alice B. Gottlieb; Tiffani Hamilton; Ivor Caro; Paul Kwon; Peter G. Compton; Cra 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 298 KB

Impact of adalimumab treatment on health

✍ D. Revicki; M.K. Willian; J.-H. Saurat; K.A. Papp; J.-P. Ortonne; C. Sexton; A. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

Patient-reported outcomes in moderate-to

✍ S. Tyring; J. Bagel; C. Lynde; P. Klekotka; E.H.Z. Thompson; S.R. Gandra; Y. Shi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB